Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01500356 · ClinicalTrials.gov registry record · NA

Effect of Exercise and Weight Loss on Cardiovascular Health

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
383
Enrollment target

NCT01500356: Completed NA study, sponsored by University of Pittsburgh.

NCT01500356 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 383 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01500356, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
383 participants
Enrollment target

Study Summary

The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity \[moderate physical activity (MOD-PA) = 150 min/wk\] versus a higher dose of physical activity \[high physical activity (HIGH-PA) = 250 min/wk\] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes.

Primary Outcome

Left ventricular mass will be assessed using cardiac MRI

Interventions

  • BEHAVIORAL Behavioral weight loss intervention
  • BEHAVIORAL Diet Plus Moderate Exercise
  • BEHAVIORAL Diet Plus High Exercise

Trial Details

FieldValue
Enrollment Target 383 participants
Start Date 2011-12-13
Est. Completion 2016-06-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT01500356 record still lists

NCT01500356 is an interventional study that assigns participants to a tested intervention. The registered 383 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 0 conditions, and to 3 interventions - of which Behavioral weight loss intervention is the first listed.

NCT01500356 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01500356 about?

NCT01500356 is a clinical study titled "Effect of Exercise and Weight Loss on Cardiovascular Health". The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity \[moderate physical activity (MOD-PA) = 150 min/wk\] versus a higher dose of physical activity \[high physical activity (HIGH-PA) = 250 min/wk\] in the context of a comprehens...

What is the current status of trial NCT01500356?

This trial is currently completed. It is a NA study. The enrollment target is 383 participants. The study started on 2011-12-13. Estimated completion is 2016-06-30.

What interventions are being tested in trial NCT01500356?

The interventions under investigation include: Behavioral weight loss intervention (BEHAVIORAL), Diet Plus Moderate Exercise (BEHAVIORAL), Diet Plus High Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01500356?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01500356's enrollment target sits among peer trials

383 273rd of 2000 higher than 1,728 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06056830 · 383 participants · Phase 3

    Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01500356, the US trial registry maintained by the National Library of Medicine. NCT01500356 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.